This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pexacerfont

Bristol-Myers Squibb Company

Drug Names(s): BMS-562086

Description: Pexacerfont is a CRF-1 antagonist. CRF-R1 is an important mediator in the stress response. Cells in the anterior lobe of the pituitary gland known as corticotropes express the receptor and will secrete adrenocorticotropic hormone (ACTH) when stimulated.


Pexacerfont News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug